PMHNP Scope of Practice for Anxiety in California

If you’re a psychiatrist or PMHNP treating anxiety disorders, you’ve probably wondered: Can I legally prescribe benzodiazepines via telehealth? What about SSRIs? Do I need to see patients in person first?

The answer depends on where you practice and what you’re prescribing. As of 2025, federal rules still allow remote prescribing of controlled anxiety medications—but this is temporary, and state laws add another layer of complexity.

Let’s break down what you need to know to treat anxiety patients via telehealth compliantly and confidently.

Federal Rules: DEA Extends Telehealth Flexibilities Through 2025

Here’s the headline: The DEA has extended COVID-era telehealth prescribing rules through December 31, 2025. This means you can prescribe Schedule II-V controlled substances—including benzodiazepines for anxiety—via telemedicine without an initial in-person exam.

Before COVID-19, the Ryan Haight Act required an in-person medical evaluation before prescribing any controlled substance ‘by means of the Internet.’ But in March 2020, federal authorities invoked a public health emergency exception, and the DEA has extended these flexibilities three times since.

What this means for anxiety treatment: You can currently prescribe alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and other Schedule IV benzodiazepines after a telehealth evaluation alone. No in-person visit required—yet.

The catch: This is temporary. In 2023, the DEA proposed rules that would have reinstated in-person requirements (allowing only a 30-day telehealth supply initially). After 38,000+ public comments and massive pushback from providers, the DEA postponed those rules to chart ‘a new path forward for telemedicine.’

Translation: New restrictions could come in 2026 or beyond. Many psychiatrists are already planning hybrid models—partnering with local clinics or preparing for potential in-person exam requirements if the rules change.

What you must do now:

• Maintain a valid DEA registration in your state of practice
• Conduct thorough telehealth evaluations (typically live video, not phone-only for new patients)
• Document the encounter as you would in-person
• Check your state’s Prescription Drug Monitoring Program (PDMP) as required
• Stay alert for DEA rule changes throughout 2025-2026

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists vs PMHNPs: Who Can Prescribe What?

Psychiatrists: Full Scope, Full Authority

As a psychiatrist (MD/DO), your scope is straightforward: you can diagnose and prescribe any medication for anxiety in all 50 states, independently, without supervision.

This includes:

• Non-controlled medications (SSRIs, SNRIs, buspirone, hydroxyzine)
• Schedule IV benzodiazepines (alprazolam, lorazepam, clonazepam)
• Schedule II controlled substances if clinically appropriate (rare in anxiety treatment, but no legal barrier)

You don’t need a collaborative agreement. You don’t need anyone’s permission. Your medical license grants full prescribing authority.

The regulatory considerations for psychiatrists:

1. Multi-state licensure: You must be licensed in every state where patients are located. California, New York, Texas, Florida, Pennsylvania, and Illinois each require their own license (though TX, FL, PA, and IL are in the Interstate Medical Licensure Compact, which simplifies the process).

2. PDMP compliance: Almost every state mandates checking the Prescription Drug Monitoring Program before prescribing controlled substances. For example:

• New York requires PDMP checks before every Schedule II-IV prescription
• Florida requires checks before any controlled substance and every 90 days for ongoing therapy
• Pennsylvania specifically requires PDMP checks each time you prescribe benzodiazepines or opioids

1. E-prescribing: Most states now require electronic prescribing. California and New York mandate it for all medications. Texas and Florida require it for controlled substances.

PMHNPs: State-by-State Variation

As a PMHNP, you can legally treat anxiety and prescribe medications in all states—but how independently you can practice varies dramatically by state.

Full Practice Authority States (for experienced NPs):

• New York: After 3,600 hours of practice, you can prescribe independently without physician oversight (made permanent in 2022)
• Illinois: After 4,000 hours and additional training, you can obtain Full Practice Authority to prescribe on your own (with a consultation relationship for Schedule II narcotics in the first 5 years)
• California: By January 2026, experienced NPs can practice fully independently; currently transitioning through 2023-2025 with limited independent practice in certain settings

Restricted Practice States (physician collaboration required):

• Texas: You must have a Prescriptive Authority Agreement with a physician. Major limitation: Texas APRNs cannot prescribe Schedule II controlled substances in outpatient settings (only in hospitals or hospice). Fortunately, most anxiety medications are Schedule IV (benzos), not Schedule II.
• Florida: You must practice under a physician’s supervisory protocol. Psychiatric NPs get special consideration—they can prescribe Schedule II medications for mental health conditions without the usual 7-day supply limit.
• Pennsylvania: You must have a collaborative agreement with a physician. You can prescribe Schedule II for up to 30 days and Schedule III-IV for up to 90 days per prescription.

What this means practically: If you’re joining a telehealth platform like Klarity Health, the platform needs physician collaborators available in restricted states so you can legally prescribe. In full-practice states, you can operate independently—simplifying deployment and giving you more autonomy.

State-Specific Telehealth Prescribing Rules

Beyond federal DEA rules and scope of practice, each state has its own telehealth prescribing requirements. Here’s what matters for the six largest markets:

California

The short version: Telehealth-friendly. No mandatory in-person exam before prescribing if your telehealth evaluation meets the standard of care.

• You can establish care via video, phone, or even asynchronous methods (questionnaires) if clinically appropriate
• No state restrictions on controlled substance prescribing via telehealth beyond federal law
• Must check CURES PDMP at least every 4 months for Schedule II-IV prescriptions
• E-prescribing required for all medications (since 2022)
• Out-of-state providers need a full California license (CA is not in the IMLC)

Texas

The short version: Generally permissive for mental health, with a key exception.

• You can prescribe via telehealth after establishing care through real-time audio-visual interaction
• Exception: Texas prohibits teleprescribing Schedule II controlled substances for chronic pain (doesn’t affect anxiety treatment)
• Mandatory PDMP check for all prescriptions of opioids, benzodiazepines, barbiturates, or carisoprodol
• Texas joined the IMLC in 2021, making multi-state licensing easier for psychiatrists
• NPs face significant restrictions (cannot prescribe Schedule II outpatient)

Florida

The short version: Explicitly allows psychiatric telehealth prescribing, with clear rules.

• Florida prohibits Schedule II prescribing via telehealth—except for four scenarios, including ‘treatment of a psychiatric disorder’
• This carve-out means psychiatrists and PMHNPs can prescribe ADHD medications (often comorbid with anxiety) and other psychiatric Schedule IIs remotely
• Out-of-state providers can register for a special Florida Telehealth Provider Registration instead of getting a full license
• Must obtain written patient consent for telehealth
• PDMP (E-FORCSE) check required before any controlled substance prescription and every 90 days thereafter
• E-prescribing mandatory for controlled substances

New York

The short version: No special restrictions; strong telehealth adoption.

• No mandatory in-person exam requirement
• I-STOP law requires PDMP checks before every Schedule II, III, or IV prescription (including all benzodiazepines)
• E-prescribing required for all medications (since 2016)
• Not in the IMLC—out-of-state psychiatrists must obtain full NY license
• Experienced NPs (3,600+ hours) can now practice fully independently

Pennsylvania

The short version: Follows federal rules; focuses on PDMP compliance.

• No state-specific in-person exam requirement
• Strongly recommends real-time audio-visual interaction for initial evaluations
• PDMP check required before prescribing any benzodiazepine or opioid—and for each subsequent prescription
• E-prescribing mandatory for controlled substances (since 2019)
• Member of IMLC (easier licensing for physicians)
• NPs require collaborative agreements (no independence yet)

Illinois

The short version: Progressive telehealth laws; NP-friendly.

• No in-person exam requirement
• Explicitly allows audio-only telehealth for mental health services if video isn’t available
• Experienced NPs can obtain Full Practice Authority (4,000+ hours)
• PDMP registration required; must check before Schedule II prescriptions
• State controlled substance license required (in addition to DEA)
• Member of IMLC (physicians) and Nurse Licensure Compact (RNs)

The Business Reality: Why Platforms Like Klarity Make Sense

If you’re reading this, you’re probably considering telehealth practice or already doing it. Here’s what many providers don’t realize: building your own telehealth anxiety practice is expensive and complicated.

The DIY marketing reality:

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow—and you need technical expertise or a costly agency
• Google Ads for mental health keywords cost $15-40+ per click, and most clicks don’t convert to booked patients. Realistic cost per booked patient: $200-400+ after optimization
• Directory listings (Psychology Today, Zocdoc) charge monthly fees, you compete with hundreds of providers on the same page, and Zocdoc charges $35-100+ per booking on top of subscription fees
• When you factor in agency fees, ad spend testing, staff time to qualify leads, no-show rates from cold leads, and failed campaigns, most solo providers spend $3,000-5,000/month with uncertain results

Klarity Health’s model removes this risk entirely:

• Pay-per-appointment model—you only pay when a qualified patient books with you
• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs to maintain HIPAA compliance, e-prescribing, etc.)
• Both insurance and cash-pay patient flow
• You control your schedule completely

Instead of gambling $50,000+ annually on marketing channels that might not work, you get guaranteed ROI: every dollar you spend brings a real patient appointment. For providers starting out or scaling up, this removes the biggest barrier to telehealth success—patient acquisition.

Common Compliance Pitfalls (And How to Avoid Them)

1. Forgetting multi-state PDMP checksEach state has its own PDMP system. If you’re licensed in multiple states, you must check the appropriate state’s database for each prescription. Set up accounts in advance and integrate PDMP access into your workflow.

2. Using phone-only for new controlled substance prescriptionsWhile some states allow audio-only telehealth for mental health, the DEA and most state medical boards expect video interaction for initial evaluations when prescribing controlled substances. Save phone-only for established patient follow-ups.

3. Not documenting telehealth consentStates like Florida explicitly require written telehealth consent. Even where it’s not legally mandated, document that you explained telehealth’s nature, limitations, and obtained the patient’s verbal or electronic consent.

4. Assuming your scope in one state applies everywhereA Texas PMHNP cannot prescribe Schedule II medications the way a Florida psychiatric NP can. A California psychiatrist’s e-prescribing system must meet different requirements than Texas. Don’t assume—verify each state’s specific rules.

5. Missing e-prescribing mandatesPaper prescriptions for controlled substances are essentially obsolete in most states. Ensure your telehealth platform or EHR has DEA-compliant EPCS (Electronic Prescribing of Controlled Substances) with two-factor authentication.

What’s Coming in 2026 and Beyond

Federal level: Watch for DEA’s final telemedicine prescribing rule. The current extension runs through December 31, 2025. The DEA may introduce:

• Special telemedicine registration requirements
• Hybrid models (initial telehealth prescription allowed, but in-person exam required within 30-180 days)
• Different rules for different drug schedules

State level: The trend is toward more autonomy for NPs and broader telehealth acceptance:

• More states are granting full practice authority to experienced PMHNPs
• Interstate compacts (IMLC for physicians, potential APRN Compact expansion) are growing
• Prescription monitoring programs are becoming more integrated with EHRs
• Audio-only telehealth is being restricted in some states (video becoming the standard)

For anxiety treatment specifically: Expect continued scrutiny of benzodiazepine prescribing regardless of modality (telehealth or in-person). State medical boards are focused on:

• Avoiding co-prescribing benzos with opioids
• Appropriate duration of benzodiazepine therapy
• Documentation of alternative treatments tried (SSRIs, therapy, etc.) before long-term benzos

The Bottom Line

Treating anxiety via telehealth is legal, clinically effective, and in high demand—but you must navigate a complex regulatory landscape. As of early 2026:

✅ Federal rules allow remote controlled substance prescribing through Dec 31, 2025 (but prepare for changes)

✅ Psychiatrists can prescribe independently in all states (with proper licensing and PDMP compliance)

✅ PMHNPs face state-by-state variation (from full independence to required collaboration)

✅ Each state has unique telehealth and prescribing rules you must follow

✅ Joining a platform like Klarity removes the patient acquisition risk and handles much of the compliance infrastructure

The anxiety treatment space has massive demand—Americans are searching for accessible mental health care more than ever. If you can navigate the regulations (or partner with a platform that does), telehealth offers an exceptional opportunity to build a sustainable, rewarding practice while genuinely improving patient access.

Ready to explore telehealth anxiety treatment? Whether you’re a psychiatrist looking to expand into new states or a PMHNP navigating scope of practice complexities, understanding these regulations is step one. Platforms like Klarity Health handle the patient acquisition, compliance infrastructure, and credentialing complexity—letting you focus on what you do best: treating patients.

Frequently Asked Questions

Can I prescribe Xanax via telehealth in 2026?Yes, under current federal rules (extended through December 31, 2025). You must conduct an appropriate telehealth evaluation (typically video), check your state’s PDMP, and follow state-specific prescribing laws. This flexibility may change when the DEA issues new rules.

Do I need to see an anxiety patient in person before prescribing?Not currently, thanks to COVID-era DEA waivers. However, you must establish a valid provider-patient relationship via telehealth that meets the standard of care. Some states (like Texas) require real-time audio-visual interaction for new patients.

What’s the difference between what psychiatrists and PMHNPs can prescribe for anxiety?Psychiatrists can prescribe any medication independently in all states. PMHNPs can prescribe anxiety medications in all states, but some states require physician collaboration agreements, and a few states (like Texas) restrict NP prescribing of Schedule II controlled substances in outpatient settings. Most anxiety medications (SSRIs, SNRIs, benzodiazepines) are not affected by these restrictions.

Which states let PMHNPs practice independently?As of 2026, experienced PMHNPs have full practice authority in New York (after 3,600 hours), Illinois (after 4,000 hours plus training), and California (transitioning to full independence by January 2026). Texas, Florida, and Pennsylvania still require physician collaboration for NP practice.

Do I need separate licenses for each state where I treat patients?Yes. You must be licensed in the state where the patient is located during the telehealth visit. The Interstate Medical Licensure Compact (IMLC) simplifies this for physicians in member states (Texas, Florida, Pennsylvania, Illinois—but not California or New York). PMHNPs need state-specific APRN authorization in each state.

What happens if the DEA changes telehealth prescribing rules?The DEA is expected to issue new rules after December 31, 2025. These may require in-person exams within a certain timeframe, create special telemedicine registration categories, or maintain current flexibilities. Providers should monitor DEA announcements and be prepared to adapt their practice models—potentially partnering with local clinics for in-person exams if required.

Citations and Sources

1. DEA and HHS Extend Telemedicine Flexibilities Through 2025 – U.S. Drug Enforcement Administration, November 15, 2024
   https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. State Telehealth Policies for Online Prescribing – Center for Connected Health Policy, updated January 9, 2026
   https://www.cchpca.org/topic/online-prescribing/

3. Florida Statutes § 456.47 (Telehealth Services) – Florida Legislature, 2025 edition
   https://www.flsenate.gov/Laws/Statutes/2025/456.47

4. Texas Board of Nursing – APRN Prescriptive Authority FAQ – Texas Board of Nursing, updated December 9, 2025
   https://www.bon.texas.gov/faqpracticeaprn.asp.html

5. New York I-STOP/Prescription Monitoring Program – New York State Department of Health, effective August 27, 2013 (accessed 2025)
   https://health.ny.gov/professionals/narcotic/prescription_monitoring

Source:

• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=forward%20for%20telemedicine%2C%20DEA%20and,through%20the%20end%20of%202024
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Controlled%20Substance%20Act
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Note%20that%20the%20practice%20of,chapter%205%20of%20title%205
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,services%20within%20the%20applicable%20scope
• https://healthweb-back.health.ny.gov/professionals/narcotic/prescription_monitoring/#:~:text=Effective%20August%2027%2C%202013%2C%20most,to%20view%20dispensed%20controlled%20substance
• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=may%20prescribe%20Schedule%20II%20drugs%3F,care%20from%20a%20qualified%20hospice
• https://www.leg.state.fl.us/Statutes/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=893.03%20to%20a%207,formulary%20which%20it%20finds%20is
• https://www.flsenate.gov/Laws/Statutes/2025/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Additionally%2C%20the%20rule%20shall%20state,addiction%20medicine%2C%20or%20palliative%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=The%20Attorney%20General%20may%20issue,application%20for%20such%20special%20registration%E2%80%94